A
Axel Finckh
Researcher at Geneva College
Publications - 283
Citations - 10735
Axel Finckh is an academic researcher from Geneva College. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 47, co-authored 242 publications receiving 9037 citations. Previous affiliations of Axel Finckh include University of Geneva & University Hospital of Lausanne.
Papers
More filters
Journal ArticleDOI
FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries
Axel Finckh,D. Neto,J. Gomez-Reino,Florenzo Iannone,Elisabeth Lie,Helena Canhão,Karel Pavelka,Carl Turesson,Xavier Mariette,J.-E. Gottenberg,Merete Lund Hetland +10 more
TL;DR: The results of this large pooled RA population of mostly inadequate responders to anti-TNFs, suggest that ABA retention and response to ABA treatment are not influenced by csDMARDs cotherapy.
Journal ArticleDOI
Neurophysiologic evidence for a central sensitization in patients with fibromyalgia.
Jules Alexandre Desmeules,Christine Cedraschi,Elisabetta Rapiti,E Baumgartner,Axel Finckh,P Cohen,Pierre Dayer,T L Vischer +7 more
TL;DR: The results strongly point to a state of central hyperexcitability of the nociceptive system in patients with FM, and the NFR can be used to assess central allodynia in FM.
Journal ArticleDOI
Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.
TL;DR: These results support the existence of a critical period to initiate antirheumatic therapy, a therapeutic window of opportunity early in the course of RA associated with sustained benefit in radiographic progression for up to 5 years.
Journal ArticleDOI
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Selidji T Agnandji,Angela Huttner,Madeleine E Zinser,Patricia Njuguna,Christine Dahlke,José Francisco Fernandes,Sabine Yerly,Julie-Anne Dayer,Verena Kraehling,Rahel Kasonta,A.A. Adegnika,Marcus Altfeld,Floriane Auderset,Emmanuel B. Bache,Nadine Biedenkopf,Saskia Borregaard,Jessica S Brosnahan,Rebekah Burrow,Christophe Combescure,Jules Alexandre Desmeules,Markus Eickmann,Sarah Katharina Fehling,Axel Finckh,Ana Rita Gonçalves,Martin P. Grobusch,Jay W. Hooper,Alen Jambrecina,Anita Lumeka Kabwende,Gürkan Kaya,Domtila Kimani,Bertrand Lell,Barbara Lemaître,Ansgar W. Lohse,Marguerite Massinga-Loembe,Alain Matthey,Benjamin Mordmüller,Anne Nolting,Caroline Ogwang,Michael Ramharter,Jonas Schmidt-Chanasit,Stefan Schmiedel,Peter Silvera,Felix R. Stahl,Henry M. Staines,Thomas Strecker,Hans Stubbe,Benjamin Tsofa,Sherif R. Zaki,Patricia E. Fast,Vasee S. Moorthy,Laurent Kaiser,Sanjeev Krishna,Stephan Becker,Marie-Paule Kieny,Philip Bejon,Peter G. Kremsner,Marylyn M. Addo,Claire-Anne Siegrist +57 more
TL;DR: RVSV-ZEBOV was reactogenic but immunogenic after a single dose and warrants further evaluation for safety and efficacy, and glycoprotein-binding antibody titers were sustained through 180 days in all participants.
Journal ArticleDOI
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
Danielle M. Gerlag,Karim Raza,Lisa G. M. van Baarsen,Elisabeth Brouwer,Christopher D. Buckley,Gerd R Burmester,Cem Gabay,Anca I. Catrina,Andrew P. Cope,François Cornelis,Solbritt Rantapää Dahlqvist,Paul Emery,Stephen Eyre,Axel Finckh,Johanna M. W. Hazes,Annette H M van der Helm-van Mil,Tom W J Huizinga,Lars Klareskog,Tore K Kvien,Cathryn M. Lewis,Klaus P Machold,Johan Rönnelid,Dirkjan van Schaardenburg,Georg Schett,Josef S Smolen,Sue Thomas,Jane Worthington,Paul P. Tak +27 more
TL;DR: Recommendations provide guidance on approaches to describe phases before the development of RA that will facilitate communication between researchers and comparisons between studies and an approach to dating disease onset was recommended.